{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:15:02Z","timestamp":1774034102717,"version":"3.50.1"},"reference-count":49,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2020,10,2]]},"DOI":"10.1080\/17512433.2020.1822163","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T13:09:29Z","timestamp":1599743369000},"page":"1159-1167","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["A narrative review of buprenorphine in adult cancer pain"],"prefix":"10.1080","volume":"13","author":[{"given":"Matthew","family":"Degnan","sequence":"first","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaker A.","family":"Mousa","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"cit0001","unstructured":"World Health Organization. Latest global cancer data: cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. 2018 [cited 2019 Aug 19]. Available from: https:\/\/www.who.int\/cancer\/PRGlobocanFinal.pdf"},{"issue":"3","key":"cit0002","first-page":"381","volume":"3","author":"Nersesyan H","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0712-5"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1627"},{"key":"cit0005","unstructured":"American Cancer Society. Opioids for cancer pain 2019. [cited 2019 Aug 13]. Available from: https:\/\/www.cancer.org\/treatment\/treatments-and-side-effects\/physical-side-effects\/pain\/opioid-pain-medicines-for-cancer-pain.html"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000170"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1177\/104990910302000213"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215627502"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25090"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.6916"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu011"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06352.x"},{"key":"cit0013","unstructured":"Drug Enforcement Agency, Departmend of Justice. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III [Rule]. 2002 [cited 2019 Dec 23]. Available from: https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2002\/fr1007.htm"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0038"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.4103\/IJPC.IJPC_83_18"},{"key":"cit0016","unstructured":"Butrans (buprenorphine) [package insert]. Stamford, CT: Purdue Pharma L.P. 2014 [cited 2020 Apr 9]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021306s015s019lbl.pdf"},{"issue":"3","key":"cit0017","first-page":"1218","volume":"297","author":"Seifert R","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01186-2"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.4081\/ejtm.2019.8098"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2015-000939"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2011.06.003"},{"key":"cit0022","volume-title":"Palliative care formulary (PCF6)","author":"Twycross R","year":"2017","edition":"6"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1177\/009127009703700106"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei145"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael051"},{"key":"cit0028","first-page":"i2732","volume":"353","year":"2016","journal-title":"BMJ"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2008.054734"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1270156"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/add.13013"},{"key":"cit0032","unstructured":"World Health Organization. WHO\u2019s cancer pain ladder for adults. 2019 [cited 2020 Apr 9]. Available from: https:\/\/www.who.int\/cancer\/palliative\/painladder\/en\/"},{"key":"cit0033","unstructured":"World Health Organization. WHO guidelines for the pharmicological and radiotherapeutic management of cancer pain in adults and adolescents. [updated 2018; cited 2020 Apr 9]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/279700\/9789241550390-eng.pdf?ua=1"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.09.011"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-005-1044-x"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00082-1"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S141007"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw097"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12669"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190717091230"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0197"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000002718"},{"key":"cit0043","volume-title":"Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"cit0044","unstructured":"Morphine sulfate injection [package insert]. Lake Forrest, IL: Hospira Inc. 2011 [cited 2020 Apr 9]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/202515s000lbl.pdf"},{"key":"cit0045","unstructured":"OxyContin (oxycodone) [package insert]. Stamford, CT: Purdue Pharma. 2007 [cited 2020 Apr 9]. Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/020553s059lbl.pdf"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X53315"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000160935.62883.ff"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31827ab599"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz356"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2020.1822163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T10:38:29Z","timestamp":1620470309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2020.1822163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,2]]}},"alternative-id":["10.1080\/17512433.2020.1822163"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2020.1822163","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}